Creative Biogene Launches Retrovirus Service to Support Retrovirus Expression Studies
Oct 15, 2020
Creative Biogene recently announces the release of its retrovirus service in order to improve retrovirus expression studies.
New York, USA - October 14, 2020 /MarketersMedia/ —
Creative Biogene, the world’s leading biotechnology products, and services provider focuses on offering professional support for virus-related researches and accelerates the development in the pharmaceutical and biotechnology industry, recently announces the release of its retrovirus service in order to improve retrovirus expression studies.
With years of experience, Creative Biogene is in a leading position in the development of retroviral technology, aiming to provide researchers from all over the world with valuable research tools. Creative Biogene’s team utilizes improved technology to increase the success rate of retroviral expression research, including highly efficient retroviral packaging cell lines, rapid retroviral vector construction, and methods that can significantly increase the transduction rate of retroviral vectors to multiple cell types.
Creative Biogene’s customized retrovirus production services include: 1) construction of retroviral plasmid vectors; 2) retroviral packaging; 3) retroviral purification; 4) retroviral titration. For more than ten years, Creative Biogene's retrovirus production team has built, packaged, and purified hundreds of retroviruses ranging from small-scale to large-scale purification for global customers. For more than ten years, Creative Biogene's retrovirus production team has built, packaged, and purified hundreds of retroviruses ranging from small-scale to large-scale purification for global customers. In addition, Creative Biogene has been optimizing the retrovirus production system, including retroviral plasmid construction and low endotoxin plasmid preparation, host cells used for retrovirus packaging, cell culture media, and retrovirus packaging process, small and large retrovirus purification process.
Recombinant Moloney Murine Leukemia Virus (MMLV) retroviral vector can be used as an effective viral vector tool to permanently introduce genes into a variety of dividing cells. This retroviral system has attracted much attention as a gene delivery method for generating iPS cells. Creative Biogene has developed a series of proprietary technologies and reagents in terms of titer, purity, viability and consistency, especially the MMLV vector system used in vector cloning services. Retroviral vectors can provide high-level expression of various inserted genes, such as cytokines, receptors, enzymes and growth factors, greatly improved the recombinant MMLV retrovirus production program. For each recombinant MMLV retrovirus produced by Creative Biogene, quality control includes titer measurement, sterility testing for bacteria and fungi, and mycoplasma testing.
“The custom retrovirus provided by Creative Biogene is an efficient method that can achieve stable gene expression in a wide range of dividing mammalian cells. Simply provide genetic data, or purchase ORF vectors from Creative Biogene’s extensive human, mouse or rat gene system, and we will provide packaged retroviral results based on your requirements,” said Marcia Brady, the marketing director of Creative Biogene.
About Creative Biogene
Creative Biogene, as a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.
Contact Info:
Name: Marcia Brady
Email: Send Email
Organization: Creative Biogene
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Phone: 16316197922
Website: https://www.creative-biogene.com/
Source: MarketersMedia
Release ID: 88980883
More News
Mortgage Rates Hit 7% as Iran War Fallout Crushes a Weak Housing Market
The average rate on a 30-year mortgage in the United States jumped to 7.03 percent, putting pressure on housing affordability.
Elizabeth Holmes to Transfer to Halfway House in August 2027
The founder of the blood-testing start-up Theranos was sentenced to 11 years in prison for fraud and had been serving time at a minimum-security federal prison in Texas.
Massachusetts Is Investigating Gambling Companies’ Use of A.I.
In response to a New York Times report on DraftKings, the state’s gaming commission said it would evaluate how each company deployed the technology.
Abortion Pills, Vaccines and Food Safety: F.D.A. Nominee Heidi Overton Faces Senate Confirmation Hearing
Dr. Heidi Overton was pressed on the president’s false statements about the measles vaccine and his intervention in tobacco policy.
Bond Markets Are Volatile and Oil Prices Rise
The rise came a day after a sharp sell-off in government debt.
Conservative Outlets Offer Trump Feed While White House TV Pool Is Suspended
Real America’s Voice and LindellTV have teamed up to provide a feed of daily presidential events.
After a Summer of Disruptions, Here Are the 7 New Rules for Air Travel
Flight delays and cancellations brought on by weather, technology glitches and other issues offer a lesson: Be prepared and be flexible.
The ‘Monster’ Behind Russia’s Global Effort to Evade Western Sanctions
A Moscow firm uses shell companies and cryptocurrency to launder money, and a custom app to forge trade records, to help Russia bypass sweeping financial restrictions.
A Weary Hollywood Celebrates the Prospect of Federal Funding
In response to an exodus of movie and TV production, a bill is being introduced in Congress that would use tax credits to subsidize filming in the United States.
Why Australia chose the world's biggest political stage to reveal OpenAI hack
Australia, which has strict social media restrictions and has proposed controls on algorithms and smart glasses, announced the breach at the UN.
Starbucks to Close 250 Stores in the US
The company said the affected cafes did not meet financial or customer service expectations.
Letterboxd Sees Acquisition Interest From A24, Sony and the New York Times
A24, Sony and The New York Times Company all registered their interest in acquiring the cinephile’s paradise.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.